First DLL3-targeted therapy shows promise in SCLC Presented ByProf. Hossein Borghaei, Fox Chase Cancer Center, PA, USA TrialPhase 1 ConferenceWCLC 2022 23 August, 2022 10:43
Molecular characteristics of SCLC Presented ByDr Simon Ekman, Karolinska University Hospital, Sweden ConferenceELCC 2019 25 June, 2019 23:13